Search results

Selected filters:

North America
Market Developments

Article type

Topic

Sector

Jurisdictions

460 results found for your search

Sort options
05 December 2019

Auto IP stakeholders in Asia call for peace, prepare for war

Huawei, Nokia and top Japanese brands discussed the licensing conflicts confronting the industry in front of a packed room in Shanghai

05 December 2019

Biologics exclusivity may be sacrificed to seal NAFTA 2.0 deal

Trump administration said to be considering weakening provisions to break political gridlock over USMCA

05 December 2019

The search for the world's leading IP strategists is on

IAM is currently seeking nominations for individuals to be considered for the 2020 edition of the Strategy 300 - our unique guide to the men and women who excel in the creation of IP value

04 December 2019

Lenovo turns to Uber head for top IP role

Mulgrew jumps ship months after ride sharing-giant’s IPO; in new position will report into former Kodak CIPO Laura Quatela

29 November 2019

The 2019 brokered patent market from the buyer and seller perspective

Asking prices for patents are up from last year. However, the size of the market is down and assertion activity from NPEs may be on the rise

29 November 2019

China’s ByteDance launches first smartphone amidst US government scrutiny

Beijing-based company is expanding from software to hardware, but video app TikTok’s runaway stateside success has put a target on its back

28 November 2019

Apple’s IP chief takes top place in this year’s <em>IAM</em> Market Makers list

Jeff Myers heads the 40-strong selection of the global dealmaking elite thanks in no small part to the iPhone giant’s huge Intel patent play in the summer

22 November 2019

Three key dynamics facing automakers in Asia

IAM is bringing the region’s IP leaders together in Shanghai on December 5th for the inaugural Auto IP Asia conference

21 November 2019

US Presidential hopefuls set their sights on pharma patents

With several leading Democratic candidates threatening to circumvent pharma IP, next year’s election could prove pivotal for right owners

20 November 2019

More Data Business Congress speakers revealed

Microsoft and Intel provide the keynotes; with senior leaders from a wide range of companies confirmed to participate in groundbreaking event

14 November 2019

Legal landscape more rational now but will shift back, says Facebook IP supremo

Get your deals done now before the market begins to rebalance in favour of patent owners, Allen Lo advises licensees while speaking on panel at the annual IP Dealmakers conference

14 November 2019

Skyhawk deal with Celgene confirms growing importance of platform technologies in life sciences IP value creation

Increased focus on gene and cell-related therapies as well as falling R&D returns, promise to heighten biopharma interest in tapping into the potential of SkySTAR and other platforms

12 November 2019

US government patent suit against Gilead could be a sign of things to come

After months of Truvada controversy, Department of Justice files multi-billion dollar case against Gilead, claiming the company has declined to take a licence to its HIV PrEP rights since in 2016

08 November 2019

Micron lawyers say Hong Kong is too risky for trade secret exchange

But a US federal judge ruled last month that UMC and Fujian Jinhua can review Micron’s evidence against them in the Special Administrative Region

08 November 2019

Catch up on the most important life sciences IP developments from the past month

Read our most recent monthly round-up for key pharma and biotech IP stories from October 2019